BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Exero Medical’s Pivotal Clinical Study of xBar Approved by WCG in the US

  Exero Medical’s prospective, blinded, multi-center study of xBar has been approved by the WCG.

  January 17, 2024

   · 

  2 min read
• Drug Development

  Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

  Biomica Ltd. today announced that the final patient has been enrolled in its Phase I clinical trial.

  January 17, 2024

   · 

  5 min read
• Cellply launches its end-to-end single cell potency characterization platform VivaCyte

  Cellply S.r.l. ( Cellply ) a leading developer of analytical tools for research and quality control within the “Cell Therapy” sector, today announced the launch of its flagship product VivaCyte.®

  January 17, 2024

   · 

  4 min read
• Biotech Bay

  Veeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma

  Veeva Systems (NYSE: VEEV) today announced a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy electronic data capture (EDC) application.

  January 17, 2024

   · 

  2 min read
• Pharm Country

  Bristol Myers Squibb Data at ASCO GU 2024 Showcase Transformative Research in the Treatment of Genitourinary Cancers

  Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the American Society of Clinical Oncology 2024 Genitourinary Cancers Symposium (ASCO GU) to be held from January 25-27 in San Francisco, California.

  January 17, 2024

   · 

  48 min read
• Pharm Country

  Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

  CytoSorbents Corporation reports on excellent outcomes from a groundbreaking randomized controlled trial using CytoSorb® blood purification during heart transplant, recently published in the European Society of Cardiology journal, ESC Heart Failure.

  January 17, 2024

   · 

  7 min read
• DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution

  DiagnaMed Holdings Corp. today announced the pilot launch of CERVAI™, a world-first consumer brain health and wellness AI solution that aims to ‘raise a red flag’ for potential brain health issues by estimating brain age and providing a brain health score.

  January 17, 2024

   · 

  5 min read
• Business

  Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer

  Starlight Therapeutics today announced that Marc Chamberlain, M.D. has joined Starlight as its Chief Medical Officer.

  January 17, 2024

   · 

  8 min read
• ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

  ZyVersa announces publication of an article in the peer-reviewed journal, Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with TNBC.

  January 17, 2024

   · 

  6 min read
• BioMidwest

  Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

  Aclarion, Inc. announced the product release of Nociscan 2.6 which includes support for additional leading magnetic resonance imaging scanners.

  January 17, 2024

   · 

  4 min read